Public disclosures

Yates Clayton Clopton

Company insiders · Director · 10% owner · Genvor Inc

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-03.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Yates Clayton Clopton

Director · 10% owner · Genvor Inc

GNVR

Genvor Inc

Equity grant or award
Filing details

SEC transaction code A

Common Stock · Indirect ownership · ACT Holdings, LLC · Reported balance after transaction: 600000 · Shares issued upon Dr. Yates' conversion of $100,000 in outstanding payables owed by the Company to Dr. Yates, pursuant to his scientific advisor agreement with the Company and the Company's restructured compensation package previously approved by the Company, which permits Dr. Yates to convert amounts due to him into Company common stock. · Dr. Yates has voting and dispositive power with respect to shares held in the name of ACT Holdings, LLC, and is therefore deemed to be beneficial owner of shares held in its name.

2026-04-152026-11-03

200,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement